Article Details
Retrieved on: 2024-04-03 03:57:17
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the FDA's emergency use authorization of Pemgarda for COVID-19 pre-exposure prophylaxis, mainly for immunocompromised individuals, and compares it to its predecessor, Evusheld.
Article found on: www.verywellhealth.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here